Sequential therapy in the hospital management of lower respiratory infections
- PMID: 8585551
- DOI: 10.1016/s0002-9343(99)80305-2
Sequential therapy in the hospital management of lower respiratory infections
Abstract
Conventional treatment for patients hospitalized with lower respiratory infections, such as pneumonia or bronchitis, typically consists of parenteral antibiotic therapy for 7-10 days. The clinical evidence, however, shows that in most patients the objective and subjective indicators of infection are substantially improved within the first 2 days of treatment. Thus, many of these patients can be switched to oral antibiotics after 2-3 days of parenteral therapy, with no loss in efficacy of treatment and with substantial savings in terms of cost of care and length of hospital stay. beta-Lactam antibiotics are a frequent choice for the oral component following short-term intravenous therapy. The results of recent, large-scale comparative clinical trials support the usefulness of this treatment approach, known as sequential therapy.
Similar articles
-
Intravenous/oral sequential therapy in patients hospitalised with community-acquired pneumonia: which patients, when and what agents?Drugs. 2002;62(2):309-17. doi: 10.2165/00003495-200262020-00005. Drugs. 2002. PMID: 11817975 Review.
-
Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children.J Antimicrob Chemother. 1999 Nov;44(5):709-15. doi: 10.1093/jac/44.5.709. J Antimicrob Chemother. 1999. PMID: 10552992 Clinical Trial.
-
Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.BMC Health Serv Res. 2007 Jul 5;7:102. doi: 10.1186/1472-6963-7-102. BMC Health Serv Res. 2007. PMID: 17615073 Free PMC article. Clinical Trial.
-
A guide to the treatment of lower respiratory tract infections.Drugs. 1995 Jul;50(1):62-72. doi: 10.2165/00003495-199550010-00006. Drugs. 1995. PMID: 7588090 Review.
-
Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial.Am J Med. 2001 Oct 1;111(5):367-74. doi: 10.1016/s0002-9343(01)00868-3. Am J Med. 2001. PMID: 11583639 Clinical Trial.
Cited by
-
Intravenous/oral sequential therapy in patients hospitalised with community-acquired pneumonia: which patients, when and what agents?Drugs. 2002;62(2):309-17. doi: 10.2165/00003495-200262020-00005. Drugs. 2002. PMID: 11817975 Review.
-
Intravenous and oral antibiotics in respiratory tract infection: an international observational study of hospital practice.Pharm World Sci. 2002 Dec;24(6):247-55. doi: 10.1023/a:1021522226178. Pharm World Sci. 2002. PMID: 12512158
-
Electronic Clinical Decision Support Tools to Manage Patients with Lower Respiratory Tract Infection: Clinicians' Perspectives in Sri Lanka.Am J Trop Med Hyg. 2025 Mar 11;112(5):1168-1174. doi: 10.4269/ajtmh.24-0576. Print 2025 May 7. Am J Trop Med Hyg. 2025. PMID: 40068220 Free PMC article.
-
Pharmacokinetics of a clarithromycin suspension administered via nasogastric tube to seriously ill patients.Antimicrob Agents Chemother. 1999 May;43(5):1277-80. doi: 10.1128/AAC.43.5.1277. Antimicrob Agents Chemother. 1999. PMID: 10223952 Free PMC article.
-
Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.Eur J Clin Microbiol Infect Dis. 1997 Nov;16(11):783-8. doi: 10.1007/BF01700406. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9447898 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical